Teneligliptin: Clinical Trials

13 trials of Teneligliptin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed, 1 unknown. 5 Phase 3, 5 Phase 4, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 35Completed 5
Phase 45Completed 4, Unknown 1
Phase 13Completed 3

Follow Teneligliptin: new trials by email Literature Review of Teneligliptin trials Research Report on Teneligliptin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pharmacokinetics and Safety of HD-P023 and Co-administration of Teneligliptin and Empagliflozin High in Healthy Volunteers
HD-P023, Teneligliptin, Empagliflozin High - Healthy Volunteers
Phase 1CompletedHandok Inc.402025-03-262025-07-31
Pharmacokinetics of HD-P023 and Co-administration of Teneligliptin and Empagliflozin High in Healthy Volunteers
HD-P023, Teneligliptin, Empagliflozin - Healthy Volunteers
Phase 1CompletedHandok Inc.402024-05-102025-02-04
Pharmacokinetic Drug Interaction Between Teneligliptin and Empagliflozin
Teneligliptin, Empagliflozin, Teneligliptin and Empagliflozin - Type 2 Diabetes Mellitus
Phase 1CompletedHandok Inc.322020-09-152021-11-15
A Randomized, Placebo-controlled Clinical Trial of Teneligliptin as Quadruple Oral Combination Therapy for Type 2 DM After Failure of an Oral Triple Anti-diabetic Regimen
teneligliptin, Placebo - Type 2 Diabetes Mellitus
Phase 4CompletedYonsei University1002020-07-082021-06-09
Tenelia Elderly CGMS Study(TEDDY)
Teneligliptin, Placebo - Type 2 Diabetes Mellitus
Phase 4CompletedHandok Inc.652018-04-032022-06-30
Teneligliptin Versus Linagliptin in Diabetes Mellitus Type Two Patients
Teneligliptin, Linagliptin - Type2 Diabetes Mellitus
Phase 4CompletedHandok Inc.1682017-01-012019-02-22
Exploratory Study to Compare the Effects of Tenelia® or Januvia® on Glucose Variability in add-on to Metformin (CGMS Study)
Teneligliptin, Sitagliptin - Type 2 Diabetes Mellitus
Phase 4CompletedHandok Inc.392015-08-272025-01-27
Teneligliptin on the Progressive Left Ventricular Diastolic Dysfunction With Type 2 Diabetes Mellitus Study
Teneligliptin - Diabetes Mellitus, Type 2
Phase 4UnknownNational Cerebral and Cardiovascular Center, Japan9362015-06-012018-08-22
Tenelia Triple Combination Study
Teneligliptin - Type 2 Diabetes Mellitus
Phase 3CompletedHandok Inc.2012015-04-012018-05-02
Confirmatory Study of MT-2412 in Japanese Patients With Type 2 Diabetes (Add-on Study of Canagliflozin)
Teneligliptin, Canagliflozin, Placebo - Type 2 Diabetes Mellitus
Phase 3CompletedTanabe Pharma Corporation1382015-01-012026-01-07
Confirmatory Study of MT-2412 in Japanese Patients With Type 2 Diabetes (Add-on Study of Teneligliptin)
Canagliflozin, Teneligliptin, Placebo - Type 2 Diabetes Mellitus
Phase 3CompletedTanabe Pharma Corporation1542015-01-012026-01-07
Long-term Safety Study of MP-513 in Patients With Type 2 Diabetes
teneligliptin, glinide, biguanide - Type 2 Diabetes Mellitus
Phase 3CompletedTanabe Pharma Corporation4622011-02-012026-01-02
Long-term Safety Study of MP-513 as Monotherapy or in Combination With Sulfonylurea in Japanese Type 2 Diabetic Patients
Teneligliptin, Teneligliptin + Sulfonylurea - Type 2 Diabetes Mellitus
Phase 3CompletedTanabe Pharma Corporation2402009-08-012026-01-05

Conditions studied

Diabetes Mellitus, Type 2 (10)  ·  Insulin Resistance (1)

Sponsors

Handok Inc. (7)  ·  Tanabe Pharma Corporation (4)  ·  National Cerebral and Cardiovascular Center, Japan (1)  ·  Yonsei University (1)

Countries

South Korea (8)  ·  Japan (5)

Top investigators

Kazuoki Kondo, MD (3)  ·  Takashi Kadowaki, Professor (2)  ·  JH Kim (1)  ·  Kazuoki Kondo, M.D. (1)  ·  Sin Gon Kim, MD, Ph.D (1)  ·  Takashi Kadowaki, M.D. (1)  ·  Takashi Kadowaki, MD (1)

Results publications

PMID 25861982, PMID 28177187, PMID 28786530, PMID 34130378